SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

EXOZ

Exozymes Inc.
NASDAQHealth Care

Latest close: 4.09 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 18, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 26, 2026Reported purchase · Form 4Michael Heltzen, Chief Executive Officer · $30.3Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1080 flagged findings
Reported transactions (Form 4)29since Nov 8, 2024 · and 36 other holdings
Corporate events (8-K)7since Nov 18, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as IZTC.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 108)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 268-K ↗Current report · Other events
  • Sep 28, 26DEFA14A ↗Shareholder meeting and votes
  • Sep 28, 26DEF 14A ↗Shareholder meeting and votes
  • Sep 18, 268-K ↗Current report · Other events
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Aug 13, 2610-Q ↗Quarterly report
  • Jul 1, 268-K ↗Current report · Entered a material agreement
  • Jun 30, 26424B5 ↗Securities offering
  • Jun 26, 268-K ↗Current report · Communication to the market
  • Jun 17, 268-K ↗Current report · Entered a material agreement
  • Jun 8, 268-K ↗Current report · Entered a material agreement
  • Jun 8, 26424B5 ↗Securities offering
  • Jun 4, 26424B5 ↗Securities offering
  • May 29, 26424B5 ↗Securities offering
  • May 14, 2610-Q ↗Quarterly report
  • May 7, 268-K ↗Current report · Other events
  • Apr 10, 268-K ↗Current report · Other events
  • Apr 10, 26Form 4 ↗Insider transaction
  • Apr 9, 26424B5 ↗Securities offering
  • Apr 8, 26Form 4 ↗Insider transaction
  • Apr 8, 26Form 3 ↗Insider transaction
  • Apr 8, 26Form 4 ↗Insider transaction

108 filings on record, the oldest from Feb 9, 24.

Listing the 25 most recent filings of the 108 on record.

8-Ks, explained

Structure5Governance2
  • Structure4 material agreements entered2025 – 2026show all 4hide
    • Jul 1, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Jun 17, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jun 8, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jun 26, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jun 20, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 21, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 18, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 26, 26Buy$30Michael HeltzenChief Executive Officer↗
  • Aug 26, 26Buy$2KMichael HeltzenChief Executive Officer↗
  • Aug 26, 26Buy$2KMichael HeltzenChief Executive Officer↗
  • Aug 25, 26Buy$2KMichael HeltzenChief Executive Officer↗
  • Aug 25, 26Buy$750Michael HeltzenChief Executive Officer↗
  • Apr 9, 26Sell$8KTyler Paz KormanChief Scientific Officer↗
  • Apr 8, 26Sell$8KTyler Paz KormanChief Scientific Officer↗
  • Jul 2, 25Buy$11KMichael HeltzenChief Executive Officer↗
  • Jan 17, 25Buy$19KMichael HeltzenChief Executive Officer↗
  • Jan 16, 25Buy$1KMichael HeltzenChief Executive Officer↗
  • Nov 15, 24Buy$22KMichael HeltzenChief Executive Officer↗
Stock compensation, tax and giftsshow the 13 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 19, 26Compensationamount n/aTyler Paz KormanChief Scientific Officer↗
  • Aug 19, 26Compensationamount n/aDamien Alan PerrimanChief Commercial Officer↗
  • Aug 19, 26Compensation$57KMichael HeltzenChief Executive Officer↗
  • Apr 1, 26Compensation$45KTyler Paz KormanChief Scientific Officer↗
  • Apr 1, 26Compensation$51KFouad NawazVice President- Finance↗
  • Apr 1, 26Compensation$34KPaul Hideo OpgenorthVice President, Development↗
  • Apr 1, 26Compensation$75KDamien Alan PerrimanChief Commercial Officer↗
  • Apr 1, 26Compensationamount n/aDamien Alan PerrimanChief Commercial Officer↗
  • Jun 16, 25Compensation$37KTyler Paz KormanVice President, Research↗
  • Jun 13, 25Compensation$44KFouad NawazVice President, Finance↗
  • Jun 13, 25Compensation$37KPaul Hideo OpgenorthVice President, Development↗
  • Nov 8, 24Other$785KMDB Capital Holdings, LLC↗
  • Nov 8, 24Other$15KPaul Hideo OpgenorthVice President, Development↗

The full record holds 24 transactions and goes back to Nov 8, 24.

Its sector and its market

Exozymes Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Exozymes Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Exozymes Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
108 documents on file, from Feb 9, 2024 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Exozymes Inc. (EXOZ): stock price history, insider trades and SEC filings — HornScout